Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
G1 Therapeutics, Inc. Banner

G1 Therapeutics, Inc.

GTHX Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-6.678m-20.263m-30.291m-60.121m-85.288m-122.447m-99.254m-148.352m-147.559m-47.967m
Depreciation & Amortization
17.314K42.000K67.226K89.000K175.000K356.000K582.000K469.000K530.000K513.000K
Change in Working Capital
207.806K946.000K3.592M6.072M573.000K6.071M-4.076m-8.838m-5.307m-5.203m
Operating Cash Flow
-6.498m-13.845m-25.141m-50.519m-74.307m-99.571m-83.742m-132.108m-128.620m-38.337m
Capital Expenditure
-103.088k-87.000k-249.742k-294.000k-709.000k-2.716m0.0000.000-506.000k0.000
Free Cash Flow
-6.601m-13.932m-25.391m-50.813m-75.016m-102.287m-83.742m-132.108m-129.126m-38.337m
Debt Repayment
-49.474k0.0000.0000.0000.0000.000-19.380m-55.000m0.000-26.688m
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
0.00033.315M50.007M108.503M340.494M2.705M2.308M92.223M52.383M-224.000k
Common Stock Repurchased
0.000-139.455k-248.916k0.0000.0000.0000.0000.0000.0000.000
Net Change in Cash
3.694M19.244M24.367M56.507M265.478M-99.582m-61.902m13.755M-126.654m-62.376m